Emmaus Life Sciences, Inc. (OTC:EMMA)
Business/Consumer Services • Computer Services
CIK 822370
Company
Emmaus Life Sciences, Inc. operates as a biopharmaceutical company. It engages in the discovery, development, marketing and sale of innovative treatments and therapies, including those in the rare and orphan disease categories. The company was founded on March 20, 1987 and is headquartered in Torrance, CA.
Address
21250 Hawthorne Boulevard
Suite 800
Torrance, California 90503
21250 Hawthorne Boulevard
Suite 800
Torrance, California 90503
Employees
55
55
Stock Info
Close
$0.1100
$0.1100
Day Range
0.1003 - 0.1305
0.1003 - 0.1305
52 Week Range
0.0506 - 0.4000
0.0506 - 0.4000
Average volume
39.42K
39.42K
Short Interest
41.22K (08/15/19)
41.22K (08/15/19)
% of Float Shorted
0.16%
0.16%
Market Cap
$5.9M
$5.9M
Revenue
$18.39M
$18.39M
Net Income
-$10.63M
-$10.63M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman, Co-President & Chief Operating Officer Willis C Lee |
Co-President, Director & Chief Commercial Officer George Sekulich |
Independent Director Ian Zwicker MBA |
Independent Director Seah H LIm MD, PhD |
Independent Director Wei Peu Zen MBA |
SEC filings
Date | Form | Event |
---|---|---|
15 Aug, 2024 | NT 10-Q | |
17 Jul, 2024 | 8-K | |
3 Jul, 2024 | 10-K | |
3 Jul, 2024 | 8-K | |
28 May, 2024 | 8-K | |
1 Apr, 2024 | NT 10-K | |
29 Feb, 2024 | 4 | |
26 Feb, 2024 | 8-K | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
5 Feb, 2024 | 4 | |
3 Jan, 2024 | 4/A | |
22 Dec, 2023 | SC 13G | |
21 Dec, 2023 | 4 | |
20 Dec, 2023 | 8-K | |
20 Dec, 2023 | 3/A | |
19 Dec, 2023 | 4 | |
19 Dec, 2023 | 4 | |
4 Dec, 2023 | 4 | |
14 Nov, 2023 | 8-K | |
14 Nov, 2023 | 10-Q | |
4 Oct, 2023 | 8-K | CEO Change |
23 Aug, 2023 | 8-K | |
14 Aug, 2023 | 8-K | |
14 Aug, 2023 | 10-Q | |
2 Jun, 2023 | 4 | |
15 May, 2023 | 10-Q | |
15 May, 2023 | 8-K | |
31 Mar, 2023 | 10-K | |
31 Mar, 2023 | 8-K | |
7 Mar, 2023 | 8-K | |
21 Feb, 2023 | SC 13D/A | |
31 Jan, 2023 | D | |
20 Jan, 2023 | D | |
20 Jan, 2023 | 4 | |
19 Jan, 2023 | 4/A | |
19 Jan, 2023 | 8-K | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
17 Jan, 2023 | 4 | |
12 Dec, 2022 | 8-K | |
1 Dec, 2022 | 4 | |
15 Nov, 2022 | 8-K | |
14 Nov, 2022 | 10-Q | |
9 Nov, 2022 | SC 13D/A | |
3 Nov, 2022 | 4 | |
31 Oct, 2022 | 4 | |
31 Oct, 2022 | DEF 14A | |
24 Oct, 2022 | 4 | |
21 Oct, 2022 | PRE 14A | |
19 Oct, 2022 | 4 | |
17 Oct, 2022 | 4 | |
13 Oct, 2022 | 4 | |
12 Oct, 2022 | 4 | |
6 Oct, 2022 | 3 | |
6 Oct, 2022 | 8-K | |
6 Oct, 2022 | 3 | |
30 Sep, 2022 | 8-K | |
19 Aug, 2022 | 8-K | |
15 Aug, 2022 | 8-K | |
15 Aug, 2022 | 10-Q | |
10 Aug, 2022 | 8-K | |
25 Jul, 2022 | 4 | |
1 Jul, 2022 | 10-K/A | |
30 Jun, 2022 | D | |
10 Jun, 2022 | 8-K | CEO Change |
3 Jun, 2022 | 4 | |
2 Jun, 2022 | 4 | |
19 May, 2022 | 4 | |
13 May, 2022 | 10-Q | |
13 May, 2022 | 8-K | |
12 Apr, 2022 | 4 | |
31 Mar, 2022 | 8-K | |
31 Mar, 2022 | 10-K | |
2 Mar, 2022 | 4 | |
28 Feb, 2022 | 4 | |
28 Feb, 2022 | 4 | |
23 Feb, 2022 | 4 | |
18 Feb, 2022 | 4 | |
17 Feb, 2022 | SC 13D/A | |
16 Feb, 2022 | 4 | |
11 Feb, 2022 | 4 | |
9 Feb, 2022 | 4 | |
7 Feb, 2022 | 4 | |
24 Jan, 2022 | 3 | |
10 Jan, 2022 | 8-K | |
5 Jan, 2022 | 4 | |
5 Jan, 2022 | 4 | |
3 Jan, 2022 | 4 | |
30 Dec, 2021 | S-8 | |
28 Dec, 2021 | 3 | |
28 Dec, 2021 | 4 | |
22 Dec, 2021 | 4 | |
20 Dec, 2021 | 3 | |
17 Dec, 2021 | 4 | |
10 Dec, 2021 | 4 | |
6 Dec, 2021 | 4 | |
2 Dec, 2021 | 4 | |
1 Dec, 2021 | SC 13D/A | |
30 Nov, 2021 | 3 | |
30 Nov, 2021 | 4 | |
30 Nov, 2021 | 4 | |
29 Nov, 2021 | 8-K | |
26 Nov, 2021 | 4 | |
26 Nov, 2021 | 4 | |
23 Nov, 2021 | 4 | |
23 Nov, 2021 | 4 | |
19 Nov, 2021 | 4 | |
12 Nov, 2021 | 10-Q | |
22 Oct, 2021 | 4 | |
12 Oct, 2021 | 8-K | |
12 Oct, 2021 | DEF 14A | |
7 Oct, 2021 | 4 | |
30 Sep, 2021 | PRE 14A | |
29 Sep, 2021 | 4 | |
27 Sep, 2021 | 4 | |
23 Sep, 2021 | 4 | |
17 Sep, 2021 | 4 | |
17 Sep, 2021 | 4 | |
13 Sep, 2021 | 4 | |
10 Sep, 2021 | 4 | |
8 Sep, 2021 | 4 | |
2 Sep, 2021 | 4 | |
1 Sep, 2021 | 10-Q | |
1 Sep, 2021 | 10-Q | |
27 Aug, 2021 | 4 | |
26 Aug, 2021 | 10-Q | |
26 Aug, 2021 | 10-Q | |
26 Aug, 2021 | 4 | |
26 Aug, 2021 | 10-Q | |
23 Aug, 2021 | 4 | |
18 Aug, 2021 | 4 | |
13 Aug, 2021 | 4 | |
10 Aug, 2021 | 10-K/A | |
10 Aug, 2021 | 4 | |
10 Aug, 2021 | 8-K | |
5 Aug, 2021 | 4 | |
2 Aug, 2021 | 4 | |
28 Jul, 2021 | 4 | |
23 Jul, 2021 | 4 | |
22 Jul, 2021 | SC 13D/A | |
20 Jul, 2021 | 4 | |
15 Jul, 2021 | 4 | |
12 Jul, 2021 | 4 | |
7 Jul, 2021 | 4 | |
1 Jul, 2021 | 4 | |
28 Jun, 2021 | 4 | |
22 Jun, 2021 | 4 | |
17 Jun, 2021 | 4 | |
14 Jun, 2021 | 4 | |
9 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
28 May, 2021 | 4 | |
28 May, 2021 | 4 | |
25 May, 2021 | 4 | |
20 May, 2021 | 4 | |
19 May, 2021 | 8-K | |
17 May, 2021 | NT 10-Q | |
14 May, 2021 | 4 | |
12 May, 2021 | 4 | |
10 May, 2021 | 4 | |
7 May, 2021 | 4 | |
4 May, 2021 | 10-K | |
31 Mar, 2021 | NT 10-K | |
22 Feb, 2021 | 8-K | |
16 Feb, 2021 | 8-K | |
16 Feb, 2021 | D | |
25 Jan, 2021 | 10-K |
Last update:2024-03-06 12:53:54.997291
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.